Hosted on MSN11mon
Penny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock Rallies
In July 2023, PaxMedica released topline data from PAX-HAT-301 Retrospective Analysis of Suramin Treatment for Stage 1 Trypanosoma Brucei Rhodesiense Human African Trypanosomiasis (S1 TBR HAT).
Technology Networks7d
New Insights Into Motion of Parasite Behind Sleeping Sickness
A research team has applied leading-edge atomic imaging and AI-driven modeling to create the most detailed 3D map yet of the ...
standardmedia.co.ke2y
Sleeping sickness: Tsetse parasite takes six weeks to reach the brain
If treatment is not carried ... According to WHO, Kenya has eliminated sleeping sickness as a public health problem. The agency targets 2030 when most African countries would have eliminated ...
Atomic imaging and AI offer new insights into motion of parasite behind sleeping sickness
Millions of people worldwide are affected by African sleeping sickness, Chagas disease and other life-threatening infections ...